Table 4.
Units of increase | Multivariate models 2–6[Link] | |
---|---|---|
OR (95% CI) | P | |
Model 2: model 1 + L‐FABP (1 SD = 0.45) | 1.37 (1.02–1.84) | 0.03 |
Model 3: model 1 + uKIM‐1 (1 SD = 0.38) | 0.86 (0.68–1.10) | 0.24 |
Model 4: model 1 + sKIM‐1 (1 SD = 0.33) | 1.50 (1.14–1.99) | 0.004 |
Model 5: model 1 + L‐FABP (1 SD = 0.45) | 1.35 (1.01–1.82) | 0.045 |
+ sKIM‐1 (1 SD = 0.33) | 1.47 (1.12–1.92) | 0.006 |
†
The effect of each biomarker was examined separately and with pairwise combinations while controlling for clinical predictors. CI, confidence interval; KIM‐1, kidney injury molecule‐1; L‐FABP, liver‐type fatty acid‐binding protein; OR, odds ratio; SD, standard deviation. The s and u prefixes denote serum and urinary sources, respectively.